Posts

Showing posts with the label Weight Loss

Being Fitter May Help Your Kidneys Age More Slowly, New Study Finds

Image
Your fitness level today could be a clue to how well your kidneys age. A new study from Japan has found that adults with higher cardiorespiratory fitness experienced a slower decline in kidney function over five years — suggesting that staying fit may help protect the kidneys long before any disease appears. The research, published in the November 2026 issue of Medicine & Science in Sports & Exercise, followed 198 adults with healthy kidney function, with a median age of 61.4 years. The team from the University of Tsukuba, led by Shun Yoshikoshi, measured each participant's cardiorespiratory fitness — the body's ability to supply oxygen during sustained activity — using a submaximal cycling test, then tracked their kidney function annually for five years. The results were clear: participants with higher fitness showed a slower decline in kidney function when it was estimated using cystatin C, a blood marker of how efficiently the kidneys filter waste. The link held even...

Your Waist Size May Matter More Than Your Weight, Massive Study of 17 Million Adults Finds

Image
Forget the number on the scale for a moment — your waistline may tell doctors far more about your health than your weight alone. A massive new study of more than 17 million adults in South Korea, published in the Journal of Epidemiology & Community Health, found that both a large waist and a very small waist are linked to a higher risk of death — no matter what a person's body mass index (BMI) says. Researchers tracked 17,252,815 adults who had routine health checks in 2009–10, following them for nearly 14 years until June 2024. During that time, about 11% of the men and 7.5% of the women died. The pattern was U-shaped: the lowest risk of death was found in men with a waist of 80–94 cm (31.5–37 inches) and women with a waist of 75–89 cm (29.5–35 inches). Risk climbed on both sides of that range — and the link held across all BMI categories and all ages, growing stronger at older ages, especially among women aged 75 and older. Among people at or above the average waist size for ...

FDA Orders New Eye Warning on Ozempic, Wegovy and All GLP-1 Drugs Over Rare Vision Risk

Image
The U.S. Food and Drug Administration has ordered a new safety warning on every GLP-1 weight-loss and diabetes drug sold in the United States, after identifying a potential increased risk of a rare eye condition that can cause sudden vision loss. In a Drug Safety Communication issued on November 9, 2026, the FDA said it is requiring manufacturers of all glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to add information about non-arteritic anterior ischemic optic neuropathy, or NAION, to the Warnings and Precautions section of their product labels. NAION, often described as an "eye stroke," is caused by reduced blood flow to the optic nerve. It can cause sudden, painless vision loss in one eye, including blind spots, tunnel vision or distorted colours, and the damage is usually not reversible. The warning covers the full GLP-1 class, including Ozempic, Wegovy and Rybelsus (semaglutide), Mounjaro and Zepbound (tirzepatide), Saxenda and Victoza (liraglutide), and Trulicity...

Popular posts from this blog

Eating Less Protein Could Slow Aging, Major Review of 350 Studies Suggests

Build Muscle, Beat Diabetes: Why Strength Training Is a Powerful Tool for Blood Sugar Control This World Diabetes Day

Your Waist Size May Matter More Than Your Weight, Massive Study of 17 Million Adults Finds